Variable hyperhomocysteinaemia phenotype in heterozygotes for the Gly307Ser mutation in cystathionine beta-synthase.

BACKGROUND A deficiency of cystathionine beta-synthase (CBS) activity is the most frequent cause of homocystinuria, an autosomal recessive disease with multiple clinical manifestations. Mutations in the CBS gene have been reported in several patients with homocystinuria. AIMS To establish the molecular basis of CBS deficiency in a female patient with pyridoxine non-responsive homocystinuria, and to apply the findings to genetic screening of her family members. METHODS The entire coding region of the CBS cDNA was amplified by PCR and used for direct sequence analysis. Mutant alleles were confirmed by direct sequence analysis of PCR-amplified genomic DNA, and by a combination of single strand conformation polymorphism and temperature gradient gel electrophoresis analysis. RESULTS The proband was homozygous for a G919A base transition which predicts the substitution of serine for glycine at codon 307 in the CBS protein (G307S). The parents (both of Irish background) were heterozygotes for the G307S allele, while an asymptomatic sibling had normal CBS sequence, Plasma homocysteine, assessed after an oral methionine load, indicated the mother clearly had moderate hyperhomocysteinaemia, whereas the father had normal concentrations of homocysteine. This is the first report of a normal methionine load test in a proven heterozygote for a CBS mutation which causes severe homocystinuria in the homozygote. Other factor(s) may have contributed to hyperhomocysteinaemia in the mother. The G307S allele has been reported in other patients and appears to be a common allele among families of Celtic origin.

[1]  V. Ramesh,et al.  Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. , 1993, Human molecular genetics.

[2]  M. Swaroop,et al.  Human cystathionine beta-synthase cDNA: sequence, alternative splicing and expression in cultured cells. , 1993, Human molecular genetics.

[3]  P. Lundberg,et al.  Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  J. Kraus,et al.  Molecular defect in a patient with pyridoxine-responsive homocystinuria. , 1993, Human molecular genetics.

[5]  J. Kraus,et al.  Rat cystathionine beta-synthase: expression of four alternatively spliced isoforms in transfected cultured cells. , 1992, Archives of biochemistry and biophysics.

[6]  M. Swaroop,et al.  Rat cystathionine beta-synthase. Gene organization and alternative splicing. , 1992, The Journal of biological chemistry.

[7]  J. Ordovás,et al.  Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[8]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[9]  D. Rosenblatt,et al.  Detection of heterozygotes for recessive alleles. Homocyst(e)inemia: paradigm of pitfalls in phenotypes. , 1990, American journal of medical genetics.

[10]  D. Wilcken,et al.  Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. , 1988, Metabolism: clinical and experimental.

[11]  U. Francke,et al.  The gene for cystathionine beta-synthase (CBS) maps to the subtelomeric region on human chromosome 21q and to proximal mouse chromosome 17. , 1988, American journal of human genetics.

[12]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[13]  D. Wilcken,et al.  Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients. , 1985, Metabolism: clinical and experimental.

[14]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[15]  D. Wilcken,et al.  Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine. , 1983, The New England journal of medicine.

[16]  D. Wilcken,et al.  Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria. , 1983, Metabolism: clinical and experimental.

[17]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[18]  B. Emmerson,et al.  Regulation of purine de novo synthesis in cultured human fibroblasts: the role of P-ribose-PP. , 1979, Biochimica et biophysica acta.

[19]  G. Turner,et al.  Homocystinuria in New South Wales. , 1978, Archives of disease in childhood.

[20]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Kraus,et al.  Screening for mutations by expressing patient cDNA segments in E. coli: Homocystinuria due to cystathionine β‐synthase deficiency , 1992, Human Mutation.